PRME
Price:
$2.705
Market Cap:
$354.79M
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2022-10-20
Stock Exchange
NASDAQ
Ticker
PRME
According to Prime Medicine, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 278.06M. This represents a change of -55.80% compared to the average of 629.13M of the last 4 quarters.
The mean historical Enterprise Value of Prime Medicine, Inc. over the last ten years is 1.16B. The current 278.06M Enterprise Value has changed 2.31% with respect to the historical average. Over the past ten years (40 quarters), PRME's Enterprise Value was at its highest in in the September 2022 quarter at 1.43B. The Enterprise Value was at its lowest in in the December 2019 quarter at 0.
Average
1.16B
Median
1.07B
Minimum
778.05M
Maximum
1.65B
Discovering the peaks and valleys of Prime Medicine, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 100.28%
Maximum Annual Enterprise Value = 1.65B
Minimum Annual Increase = -52.77%
Minimum Annual Enterprise Value = 778.05M
Year | Enterprise Value | Change |
---|---|---|
2023 | 778.05M | -52.77% |
2022 | 1.65B | 100.28% |
2021 | 822.50M | -22.88% |
2020 | 1.07B | -27.09% |
The current Enterprise Value of Prime Medicine, Inc. (PRME) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.08B
5-year avg
1.16B
10-year avg
1.16B
Prime Medicine, Inc.’s Enterprise Value is less than Beam Therapeutics Inc. (2.32B), greater than Caribou Biosciences, Inc. (145.44M), less than Intellia Therapeutics, Inc. (1.21B), less than Sana Biotechnology, Inc. (350.88M), greater than Reneo Pharmaceuticals, Inc. (25.69M), less than Ginkgo Bioworks Holdings, Inc. (368.53M), greater than Ocean Biomedical, Inc. (32.66M), less than Royalty Pharma plc (17.82B), greater than Editas Medicine, Inc. (42.54M), less than CRISPR Therapeutics AG (3.48B), less than Verve Therapeutics, Inc. (403.60M), greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than aTyr Pharma, Inc. (138.44M), less than Relay Therapeutics, Inc. (601.30M), greater than Century Therapeutics, Inc. (88.31M), less than Blueprint Medicines Corporation (6.10B),
Company | Enterprise Value | Market cap |
---|---|---|
2.32B | $2.39B | |
145.44M | $150.77M | |
1.21B | $1.23B | |
350.88M | $381.79M | |
25.69M | $60.84M | |
368.53M | $539.15M | |
32.66M | $20.55M | |
17.82B | $11.16B | |
42.54M | $99.88M | |
3.48B | $3.47B | |
403.60M | $491.05M | |
138.26M | $181.50M | |
138.44M | $131.12M | |
601.30M | $703.85M | |
88.31M | $86.30M | |
6.10B | $5.71B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prime Medicine, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Prime Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Prime Medicine, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Prime Medicine, Inc. (PRME)?
What is the 3-year average Enterprise Value for Prime Medicine, Inc. (PRME)?
What is the 5-year average Enterprise Value for Prime Medicine, Inc. (PRME)?
How does the current Enterprise Value for Prime Medicine, Inc. (PRME) compare to its historical average?